ArticleThe Journal of investigative dermatology2013

Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis.

Leon Raskin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.